These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34980147)

  • 1. Use of research evidence varied in efforts to expand specific pharmacist autonomous prescriptive authority: an evaluation and recommendations to increase research utilization.
    Kumar A; Ray AB; Blanchard C
    Health Res Policy Syst; 2022 Jan; 20(1):1. PubMed ID: 34980147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial perceptions of key stakeholders in Ontario regarding independent prescriptive authority for pharmacists.
    Pojskic N; MacKeigan L; Boon H; Austin Z
    Res Social Adm Pharm; 2014; 10(2):341-54. PubMed ID: 23816494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing pharmacist prescribing privileges: Is it time?
    Majercak KR
    J Am Pharm Assoc (2003); 2019; 59(6):783-786. PubMed ID: 31521588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Continuum of Pharmacist Prescriptive Authority.
    Adams AJ; Weaver KK
    Ann Pharmacother; 2016 Sep; 50(9):778-84. PubMed ID: 27307413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathways to pharmacist prescriptive authority: Do decentralized models for expanded prescribing work?
    Adams AJ; Frost TP
    Res Social Adm Pharm; 2022 Apr; 18(4):2695-2699. PubMed ID: 34321187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist-led Smoking-Cessation Services in the United States - A Multijurisdictional Legal Analysis.
    Bordner LS; Lavino J
    Innov Pharm; 2022; 13(1):. PubMed ID: 36304682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update and recommendations: Pharmacists' prescriptive authority for tobacco cessation medications in the United States.
    Hilts KE; Corelli RL; Vernon VP; Hudmon KS
    J Am Pharm Assoc (2003); 2022; 62(5):1531-1537. PubMed ID: 35953378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Never waste a good crisis": Opportunities and constraints from the COVID-19 pandemic on pharmacists' scope of practice.
    Chiu K; Thow AM; Bero L
    Res Social Adm Pharm; 2022 Sep; 18(9):3638-3648. PubMed ID: 35414485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enablers and challenges to pharmacy practice change in Kuwait hospitals: a qualitative exploration of pharmacists' perceptions.
    Katoue MG
    J Eval Clin Pract; 2021 Apr; 27(2):272-279. PubMed ID: 32929812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of pharmacy access to hormonal contraception.
    Dale LE; Trujillo V; Herman A; Sussman AL; Espey E; Hofler LG
    J Am Pharm Assoc (2003); 2024; 64(1):235-244.e3. PubMed ID: 37890772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key stakeholders' views on the potential implementation of pharmacist prescribing: A qualitative investigation.
    Jebara T; Cunningham S; MacLure K; Pallivalapila A; Awaisu A; Al Hail M; Stewart D
    Res Social Adm Pharm; 2020 Mar; 16(3):405-414. PubMed ID: 31253499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacists' Perspectives on Prescribing and Expanding Access to Hormonal Contraception in Pharmacies in the United States.
    Rafie S; Cieri-Hutcherson NE; Frame TR; Griffin B; Harris JB; Horlen C; Shealy K; Stein AB; Stone RH; Vest K; Westberg S; Yancey AM
    J Pharm Pract; 2021 Apr; 34(2):230-238. PubMed ID: 31390938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Federal pharmacist Paxlovid prescribing authority: A model policy or impediment to optimal care?
    Adams AJ; Eid DD
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100244. PubMed ID: 36945228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' Scope of Practice: Supports for Canadians with Diabetes.
    Mansell K; Edmunds K; Guirguis L
    Can J Diabetes; 2017 Dec; 41(6):558-562. PubMed ID: 29037573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding state laws and a growing role for pharmacists in vaccination services.
    Schmit CD; Penn MS
    J Am Pharm Assoc (2003); 2017; 57(6):661-669. PubMed ID: 28807659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Developments in Pharmacists' Scope of Practice to Address Unmet Health Care Needs.
    Burns AL
    Ann Pharmacother; 2016 Sep; 50(9):785-7. PubMed ID: 27340143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stakeholders' views on granting prescribing authority to pharmacists in Nigeria: a qualitative study.
    Auta A; Strickland-Hodge B; Maz J
    Int J Clin Pharm; 2016 Aug; 38(4):960-7. PubMed ID: 27194098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services.
    Famiyeh IM; MacKeigan L; Thompson A; Kuluski K; McCarthy LM
    Res Social Adm Pharm; 2019 May; 15(5):575-583. PubMed ID: 30100199
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.